Literature DB >> 23403552

"Sandbagging" baseline test performance on ImPACT, without detection, is more difficult than it appears.

Philip Schatz1, Colette Glatts.   

Abstract

Participants coached to display poor effort on neuropsychological tests have successfully evaded detection. Recent research has documented that 89% college athletes instructed to perform poorly on a follow-up baseline ImPACT (Immediate Post-concussion Assessment and Cognitive Testing) test were unable to bypass detection, but otherwise, sandbagging on baseline testing has not been directly studied. In an analog study intended to measure participants' ability to successfully sandbag, we compared baseline test performance in three groups of individuals, instructed: (a) to perform their best, (b) to malinger without guidance (e.g., naïve), and (c) how to malinger (e.g., coached), using ImPACT, the Medical Symptom Validity Test (MSVT), and the Balance Error Scoring System. The MSVT identified more participants in the naïve (80%) and coached (90%) groups than those automatically "flagged" by ImPACT (60% and 75%, respectively). Inclusion of additional indicators within ImPACT increased identification to 95% of naïve and 100% of coached malingerers. These results suggest that intentional "sandbagging" on baseline neurocognitive testing can be readily detected.

Entities:  

Mesh:

Year:  2013        PMID: 23403552     DOI: 10.1093/arclin/act009

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  12 in total

Review 1.  Evaluation of Cognitive Symptoms Following Concussion.

Authors:  Myron Goldberg; Renee Madathil
Journal:  Curr Pain Headache Rep       Date:  2015-09

2.  Computerized neuropsychological test performance of youth football players at different positions: A comparison of high and low contact players.

Authors:  William T Tsushima; Hyeong Jun Ahn; Andrea M Siu; Tama Fukuyama; Nathan M Murata
Journal:  Appl Neuropsychol Child       Date:  2017-02-28       Impact factor: 1.493

Review 3.  Computerized neurocognitive testing in the management of sport-related concussion: an update.

Authors:  Jacob E Resch; Michael A McCrea; C Munro Cullum
Journal:  Neuropsychol Rev       Date:  2013-12-04       Impact factor: 7.444

Review 4.  If You're Not Measuring, You're Guessing: The Advent of Objective Concussion Assessments.

Authors:  Steven P Broglio; Kevin M Guskiewicz; John Norwig
Journal:  J Athl Train       Date:  2017-03       Impact factor: 2.860

5.  Concussion Baseline Testing: Preexisting Factors, Symptoms, and Neurocognitive Performance.

Authors:  Jordan E Cottle; Eric E Hall; Kirtida Patel; Kenneth P Barnes; Caroline J Ketcham
Journal:  J Athl Train       Date:  2017-01-10       Impact factor: 2.860

Review 6.  Validity of the Immediate Post Concussion Assessment and Cognitive Testing (ImPACT).

Authors:  Bara Alsalaheen; Kayla Stockdale; Dana Pechumer; Steven P Broglio
Journal:  Sports Med       Date:  2016-10       Impact factor: 11.136

Review 7.  Neuropsychological Assessment Following Concussion: an Evidence-Based Review of the Role of Neuropsychological Assessment Pre- and Post-Concussion.

Authors:  Anthony P Kontos; Alicia Sufrinko; Melissa Womble; Nathan Kegel
Journal:  Curr Pain Headache Rep       Date:  2016-06

8.  Prevalence of Invalid Performance on Baseline Testing for Sport-Related Concussion by Age and Validity Indicator.

Authors:  Christopher A Abeare; Isabelle Messa; Brandon G Zuccato; Bradley Merker; Laszlo Erdodi
Journal:  JAMA Neurol       Date:  2018-06-01       Impact factor: 18.302

9.  Baseline Neurocognitive Performance and Clearance for Athletes to Return to Contact.

Authors:  Breton M Asken; James R Clugston; Aliyah R Snyder; Russell M Bauer
Journal:  J Athl Train       Date:  2016-12-01       Impact factor: 2.860

10.  Supervision and computerized neurocognitive baseline test performance in high school athletes: an initial investigation.

Authors:  Andrew Warren Kuhn; Gary S Solomon
Journal:  J Athl Train       Date:  2014 Nov-Dec       Impact factor: 2.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.